• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病中的神经元活动与早期神经原纤维缠结

Neuronal activity and early neurofibrillary tangles in Alzheimer's disease.

作者信息

Hatanpää K, Brady D R, Stoll J, Rapoport S I, Chandrasekaran K

机构信息

Laboratory of Neurosciences, National Institute on Aging, National Institutes of Health, Bethesda, MD 20892-1582, USA.

出版信息

Ann Neurol. 1996 Sep;40(3):411-20. doi: 10.1002/ana.410400310.

DOI:10.1002/ana.410400310
PMID:8797530
Abstract

We studied neuronal activity and its relation to the accumulation of neurofibrillary tangles in Alzheimer's disease (AD) neurons by in situ hybridization to cytochrome oxidase subunit III messenger RNA, a marker of mitochondrial energy metabolism. In AD midtemporal cortex, levels of cytochrome oxidase subunit III messenger RNA were decreased by 26% in neurons bearing early-stage neurofibrillary tangles as compared to tangle-free neurons (p < 0.01). However, levels of 12S ribosomal RNA, also encoded by mitochondrial DNA, and of total messenger RNA were decreased only in later stages of tangle development. Comparing tangle-free neurons of 4 AD brains to tangle-free neurons of 3 control brains, levels of cytochrome oxidase subunit III messenger RNA were found to be 25% lower (p < 0.001) in AD tangle-free neurons. Because energy metabolic needs of neurons are mainly determined by synaptic input, the observed decreases in cytochrome oxidase subunit III messenger RNA likely reflect downregulation due to impaired synaptic function in AD. Thus, a failure in synaptic transmission may precede tangle formation. A further decline in neuronal activity is seen as tangle formation progresses. However, these results can also be viewed as showing the viability and continuing activity, albeit at a lower level, of neurons in the early stages of neurofibrillary pathology.

摘要

我们通过原位杂交检测细胞色素氧化酶亚基III信使核糖核酸(线粒体能量代谢的一个标志物),研究了阿尔茨海默病(AD)神经元的神经活动及其与神经原纤维缠结积累的关系。在AD颞中皮质,与无缠结的神经元相比,存在早期神经原纤维缠结的神经元中细胞色素氧化酶亚基III信使核糖核酸水平降低了26%(p < 0.01)。然而,同样由线粒体DNA编码的12S核糖体核糖核酸水平以及总信使核糖核酸水平仅在缠结发展的后期阶段降低。将4例AD脑的无缠结神经元与3例对照脑的无缠结神经元进行比较,发现AD无缠结神经元中细胞色素氧化酶亚基III信使核糖核酸水平低25%(p < 0.001)。由于神经元的能量代谢需求主要由突触输入决定,观察到的细胞色素氧化酶亚基III信使核糖核酸水平降低可能反映了AD中由于突触功能受损导致的下调。因此,突触传递失败可能先于缠结形成。随着缠结形成的进展,神经活动进一步下降。然而,这些结果也可以被视为表明在神经原纤维病理早期阶段神经元具有活力并持续活动,尽管水平较低。

相似文献

1
Neuronal activity and early neurofibrillary tangles in Alzheimer's disease.阿尔茨海默病中的神经元活动与早期神经原纤维缠结
Ann Neurol. 1996 Sep;40(3):411-20. doi: 10.1002/ana.410400310.
2
Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons.阿尔茨海默病中含缠结的CA1神经元中转录本的表达谱
Ann Neurol. 2000 Jul;48(1):77-87.
3
Functional alterations in Alzheimer's disease: diminution of cytochrome oxidase in the hippocampal formation.阿尔茨海默病的功能改变:海马结构中细胞色素氧化酶的减少。
J Neuropathol Exp Neurol. 1993 Nov;52(6):580-5.
4
The neuropathological changes associated with normal brain aging.与正常脑老化相关的神经病理学变化。
Histol Histopathol. 1996 Oct;11(4):1075-88.
5
Spatial and temporal relationships between plaques and tangles in Alzheimer-pathology.阿尔茨海默病病理学中斑块与缠结之间的时空关系。
Neurobiol Aging. 2004 Jul;25(6):697-711. doi: 10.1016/j.neurobiolaging.2003.09.009.
6
Transneuronally altered dendritic processing of tangle-free neurons in Alzheimer's disease.阿尔茨海默病中无缠结神经元的跨神经元改变的树突处理
Acta Neuropathol. 2002 May;103(5):437-43. doi: 10.1007/s00401-001-0486-4. Epub 2002 Jan 30.
7
Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease.在阿尔茨海默病中,神经元丢失与神经原纤维缠结相关,但程度超过神经原纤维缠结。
Ann Neurol. 1997 Jan;41(1):17-24. doi: 10.1002/ana.410410106.
8
Neuron loss from the hippocampus of Alzheimer's disease exceeds extracellular neurofibrillary tangle formation.阿尔茨海默病患者海马体中的神经元损失超过细胞外神经原纤维缠结的形成。
Acta Neuropathol. 2002 Apr;103(4):370-6. doi: 10.1007/s00401-001-0477-5. Epub 2001 Dec 12.
9
Immunocytochemical characterization of glial fibrillary tangles in Alzheimer's disease brain.阿尔茨海默病脑内神经胶质纤维缠结的免疫细胞化学特征
Am J Pathol. 1995 May;146(5):1052-8.
10
Neurofibrillary tangles may interfere with Smad 2/3 signaling in neurons.神经原纤维缠结可能会干扰神经元中的Smad 2/3信号传导。
J Neuropathol Exp Neurol. 2007 Feb;66(2):158-67. doi: 10.1097/nen.0b013e3180303b93.

引用本文的文献

1
One Autopsy Proved Neocortical Lewy Body Disease Without the Involvement of the Olfactory Bulb and Brainstem.一例尸检证实为新皮质路易体病,未累及嗅球和脑干。
J Korean Med Sci. 2022 Jun 13;37(23):e195. doi: 10.3346/jkms.2022.37.e195.
2
Network activity changes in the pathophysiology of Alzheimer's disease: the role of aging and early entorhinal cortex dysfunction.阿尔茨海默病病理生理学中的网络活动变化:衰老和早期内嗅皮层功能障碍的作用。
Metab Brain Dis. 2022 Feb;37(2):289-298. doi: 10.1007/s11011-021-00848-8. Epub 2021 Sep 30.
3
Brain pyrimidine nucleotide synthesis and Alzheimer disease.
脑嘧啶核苷酸合成与阿尔茨海默病。
Aging (Albany NY). 2019 Sep 27;11(19):8433-8462. doi: 10.18632/aging.102328.
4
Relationships between default-mode network connectivity, medial temporal lobe structure, and age-related memory deficits.默认模式网络连通性、内侧颞叶结构与年龄相关记忆缺陷之间的关系。
Neurobiol Aging. 2015 Jan;36(1):265-72. doi: 10.1016/j.neurobiolaging.2014.06.028. Epub 2014 Jul 3.
5
Current neuroimaging techniques in Alzheimer's disease and applications in animal models.阿尔茨海默病的当前神经成像技术及其在动物模型中的应用。
Am J Nucl Med Mol Imaging. 2012;2(3):386-404. Epub 2012 Jul 10.
6
Cognitive deterioration and associated pathology induced by chronic low-level aluminum ingestion in a translational rat model provides an explanation of Alzheimer's disease, tests for susceptibility and avenues for treatment.在一个转化大鼠模型中,慢性低水平摄入铝所诱发的认知衰退及相关病理学表现为阿尔茨海默病提供了解释、易感性检测方法及治疗途径。
Int J Alzheimers Dis. 2012;2012:914947. doi: 10.1155/2012/914947. Epub 2012 Jul 30.
7
Mitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer's disease.线粒体和细胞生物能量学:越来越被认可的阿尔茨海默病的组成部分和可能的病因。
Antioxid Redox Signal. 2012 Jun 15;16(12):1434-55. doi: 10.1089/ars.2011.4149. Epub 2011 Sep 15.
8
Biomarkers and evolution in Alzheimer disease.阿尔茨海默病的生物标志物与演变。
Prog Neurobiol. 2011 Dec;95(4):510-3. doi: 10.1016/j.pneurobio.2011.07.006. Epub 2011 Jul 23.
9
Brain fuel metabolism, aging, and Alzheimer's disease.脑燃料代谢、衰老和阿尔茨海默病。
Nutrition. 2011 Jan;27(1):3-20. doi: 10.1016/j.nut.2010.07.021. Epub 2010 Oct 29.
10
A pilot study evaluating the efficacy and safety of rivastigmine in patients with mixed dementia.一项评估卡巴拉汀对混合型痴呆患者疗效及安全性的试点研究。
Drugs Aging. 2006;23(3):241-9. doi: 10.2165/00002512-200623030-00006.